These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18028382)

  • 1. Construction of a chromosome 17 transcriptome in serous ovarian cancer identifies differentially expressed genes.
    Wojnarowicz PM; Breznan A; Arcand SL; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Int J Gynecol Cancer; 2008; 18(5):963-75. PubMed ID: 18028382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes.
    Birch AH; Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2008 Jan; 47(1):56-65. PubMed ID: 17620309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.
    Presneau N; Mes-Masson AM; Ge B; Provencher D; Hudson TJ; Tonin PN
    Oncogene; 2003 Mar; 22(10):1568-79. PubMed ID: 12629520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer.
    Quinn MC; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2009 Jul; 48(7):648-61. PubMed ID: 19123201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiles of 290 ESTs mapped to chromosome 3 in human epithelial ovarian cancer cell lines using DNA expression oligonucleotide microarrays.
    Manderson EN; Mes-Masson AM; Novak J; Lee PD; Provencher D; Hudson TJ; Tonin PN
    Genome Res; 2002 Jan; 12(1):112-21. PubMed ID: 11779836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 17q25 genes, RHBDF2 and CYGB, in ovarian cancer.
    Wojnarowicz PM; Provencher DM; Mes-Masson AM; Tonin PN
    Int J Oncol; 2012 Jun; 40(6):1865-80. PubMed ID: 22344671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity and transcriptome analyses of a 1.2 Mb candidate ovarian cancer tumor suppressor locus region at 17q25.1-q25.2.
    Presneau N; Dewar K; Forgetta V; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2005 Jul; 43(3):141-54. PubMed ID: 15937959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines.
    Benoît MH; Hudson TJ; Maire G; Squire JA; Arcand SL; Provencher D; Mes-Masson AM; Tonin PN
    Int J Oncol; 2007 Jan; 30(1):5-17. PubMed ID: 17143508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of a cell adhesion molecule with homology to L1CAM, contactin 6, and contactin 4 candidate chromosome 3p26pter tumor suppressor genes in ovarian cancer.
    Manderson EN; Birch AH; Shen Z; Mes-Masson AM; Provencher D; Tonin PN
    Int J Gynecol Cancer; 2009 May; 19(4):513-25. PubMed ID: 19509545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines.
    Cody NA; Zietarska M; Filali-Mouhim A; Provencher DM; Mes-Masson AM; Tonin PN
    BMC Med Genomics; 2008 Aug; 1():34. PubMed ID: 18687136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis of gene expression mirrors the biology of an ovarian cancer model.
    Tonin PN; Hudson TJ; Rodier F; Bossolasco M; Lee PD; Novak J; Manderson EN; Provencher D; Mes-Masson AM
    Oncogene; 2001 Oct; 20(45):6617-26. PubMed ID: 11641787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome.
    Quinn MC; Wojnarowicz PM; Pickett A; Provencher DM; Mes-Masson AM; Davis EC; Tonin PN
    Int J Oncol; 2013 Mar; 42(3):912-20. PubMed ID: 23354471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
    Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
    Schaner ME; Davidson B; Skrede M; Reich R; Flørenes VA; Risberg B; Berner A; Goldberg I; Givant-Horwitz V; Tropè CG; Kristensen GB; Nesland JM; Børresen-Dale AL
    Mol Cancer; 2005 Jul; 4():26. PubMed ID: 16042759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of the metastasis-associated genes by gene chip in high metastatic human ovarian cancer cell lines.
    Xu S; Mou H; Gu L; Su D; Zhu C; Liu X
    J Genet Genomics; 2007 Jul; 34(7):581-90. PubMed ID: 17643943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential gene expression identifies subgroups of ovarian carcinoma.
    Skubitz AP; Pambuccian SE; Argenta PA; Skubitz KM
    Transl Res; 2006 Nov; 148(5):223-48. PubMed ID: 17145569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC).
    Zietarska M; Maugard CM; Filali-Mouhim A; Alam-Fahmy M; Tonin PN; Provencher DM; Mes-Masson AM
    Mol Carcinog; 2007 Oct; 46(10):872-85. PubMed ID: 17455221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.